Pacira | PCRX - 营业利润

股票价格

22.02

每天变化

0.08 0.36%

每月一次

-5.00%

每年

-9.31%

Q1 预测

22.56

金融业

USD

USD 1.26B

现金及等价物

USD 158.55M

USD 54.62M

USD 547.97M

USD 120.59M

USD 372.19M

USD 3.19M

USD 38.71M

790

EPS每股收益

USD 0.06

股本和储备

USD 693.11M

USD 142.25M

债务利息支出

USD 3.89M

USD 8.53M

USD 372.19M

USD 1.02B

USD 1.64M

USD 193.68M

USD 3.19M

普通股股本

USD 41.12M

52.68

USD 9.52M

USD 196.87M

销售和管理费用

USD 91.87M

USD 152.86M

贸易债权人

USD 15.15M

应收帐款人

USD 124.07M

	营业利润	更改		日
Assertio Holdings	USD -3.05M		569K	2024-09
Astellas Pharma	JPY 134.54B		30.13B	2025-12
Bristol-Myers Squibb	USD 4.2B		562M	2025-12
Cara Therapeutics	USD -2.39M		3.49M	2025-03
Coherus Biosciences	USD -45.43M		3.13M	2025-03
Heron Therapeutics	USD 38K		3.83M	2025-12
Ironwood Pharmaceuticals	USD 33.22M		7.58M	2024-12
J&J	USD 5.59B		1.81B	2025-12
Ligand Pharmaceuticals	USD 158.89M		149.17M	2025-09
Nektar Therapeutics	USD -34.34M		15.43M	2024-09
Novo Nordisk	DKK 32.38B		1.7B	2025-12
Omeros	USD -35.41M		23.75M	2024-09
Pacira	USD 3.19M		9.96M	2025-12
Perrigo	USD 84.4M		9M	2025-12
Pfizer	USD 4.65B		3.99B	2025-12
Supernus Pharmaceuticals	USD 13.82M		74.01M	2025-12
Teva Pharmaceutical Industries	USD 487M		581M	2025-12
Xeris Pharmaceuticals	USD 6.73M		2.25M	2025-09
Xoma	USD -15.64M		5.56M	2024-09
Zoetis	USD 835M		101M	2025-12